Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Rapportagebias in studies naar ziektemodificerende middelen bij MS
jun 2024 | Multipele Sclerose